Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arginine Butyrate +/- Epoetin Alfa in Thalassemia Intermedia
NCT00006136Phase 2Completed
- Sponsor
- Boston University
- Start
- Mar 1999
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of arginine butyrate in beta-thalassemia intermedia, sponsored by Boston University. Started Mar 1999; status: completed.
02
Drugs
arginine butyrate
03
Conditions
beta-thalassemia intermedia
Beyond the preview
Go deeper on NCT00006136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006136.